novartis glp 1 drug Thurs news: Employers drop GLP-1 weight loss coverage as use surges. J&J adds rare disease wAIHA to Imaavy's potential uses. Takeda's $4B TYK2 drug tops Bristol Myers' Sotyktu in head-to-head. Novo Nordisk Drops Hims &
Description
While robust synaptic effects have been demonstrated in animal models, consistent replication in humans remains limited, underscoring the need for translational research and validated biomarkers
Chem Biol Interact 322:108968
Liu X-Y, Wang L-X, Chen Z, Liu L-B
What happens when you stop treatment
